SCHEMBL3828896

SCHEMBL3828896

Nc1ccc2c(c1)CCC(C(=O)C(F)(F)F)NC2

nearest known ligand 0.36

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.36
ATAD2 Q6PL18 1/20 0.36
GRIN2B Q13224 1/20 0.34
HSD17B3 P37058 1/20 0.33
CRBN Q96SW2 2/20 0.33
NR1H2 P55055 1/20 0.32
SCN3A Q9NY46 1/20 0.32
CA9 Q16790 1/20 0.31
PNMT P11086 1/20 0.31
CASP1 P29466 1/20 0.30
CASP7 P55210 1/20 0.30
HSD17B10 Q99714 1/20 0.30
KDM1A O60341 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3832960 0.84 PNMT (0.46) PNMTKDM1A
SCHEMBL5752287 0.81 PNMT (0.42) PNMTHSD17B10
SCHEMBL29754050 0.81 CA9 (0.42) BRD4ATAD2GRIN2BCRBNNR1H2
SCHEMBL6627874 0.78 NR1H2 (0.45) BRD4ATAD2GRIN2BHSD17B3CRBN
SCHEMBL31370224 0.71 EGLN1 (0.44) BRD4ATAD2SCN3A
SCHEMBL28947577 0.70 ESR1 (0.52) BRD4ATAD2NR1H2
SCHEMBL4564040 0.70 PNMT (0.40) BRD4ATAD2GRIN2BHSD17B3CA9
SCHEMBL5732501 0.70 DRD2 (0.33) KDM1A
SCHEMBL5732466 0.69 MTNR1A (0.47)
SCHEMBL17797701 0.69 GRIN2B (0.39) GRIN2BCA9HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2102171-A1 NEW PYRIDAZINE DERIVATIVES WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2009-09-23 EP disclosed
WO-2008071646-A1 NEW PYRIDAZINE DERIVATIVES WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-06-19 WO disclosed